PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports

In the past decade, a growing body of literature has reported promising results for prostate-specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate cancer. First clinical studies evaluating the efficacy of [ 177 Lu]Lu-PSMA radioligand therapy (PSMA-RLT) demonstrated f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2021-12, Vol.48 (13), p.4350-4368
Hauptverfasser:	Uijen, M. J. M., Derks, Y. H. W., Merkx, R. I. J., Schilham, M. G. M., Roosen, J., Privé, B. M., van Lith, S. A. M., van Herpen, C. M. L., Gotthardt, M., Heskamp, S., van Gemert, W. A. M., Nagarajah, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Brain cancer Breast cancer Cardiology Computed tomography Dipeptides Glioblastoma Hepatocellular carcinoma Heterocyclic Compounds, 1-Ring Humans Imaging Immunohistochemistry Kidney cancer Lung cancer Lung carcinoma Lutetium isotopes Male Medical imaging Medicine Medicine & Public Health Nuclear Medicine Oncology Oncology – General Oral cancer Orthopedics Patients Positron emission Positron Emission Tomography Computed Tomography Prostate cancer Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - radiotherapy Prostatic Neoplasms, Castration-Resistant Radioisotopes Radiology Renal cell carcinoma Review Review Article Salivary gland Salivary glands Side effects Solid tumors Therapy Thyroid cancer Tomography Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!